Towards a Sex-specific "Female Enhanced Recovery After Cardiac Surgery'' (F-ERAS) Pathway:
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJennifer Breel
About this trial
The aim of this study is to evaluate the differences between men and women undergoing cardiac surgery. We will look at perioperative factors such as body weight, body surface area, previous medical history, pharmacokinetics, transfusion, coagulation, cardiopulmonary bypass (CPB) related factors, cardiac function, inotropic requirements, risk, and outcome scores as well as morbidity and mortality at 30 and 90 days, 1, 5, and 10 years.
Eligibility criteria
Qualifiers
Patients > 18 years
All patients who underwent cardiac surgery from 1 January 2016 to the start of the study, in either of the centres (AMC or VUmc) (retrospective)
All patients undergoing cardiac surgery from the start of the study (~March 2022) until approximately 2032
Disqualifiers
None
Trial design
Treatments tested in this trial
- Cardiac surgery
Treatment groups
5,500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Jennifer Breel
Lead sponsor
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Sponsor institution
Source ClinicalTrials.gov